...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of Clinical Oncology >CT2--the clinical trials control tower: overcoming barriers to opening oncology clinical trials. Clinical Oncology
【24h】

CT2--the clinical trials control tower: overcoming barriers to opening oncology clinical trials. Clinical Oncology

机译：CT2--临床试验控制塔：克服开放式肿瘤临床试验的障碍。临床肿瘤学

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

To the Editor: We read the article by Dilts and Sandier with interest, and applaud the authors' meticulous efforts and candor in illuminating the barriers that exist to opening oncology clinical trials in an academic health center setting. As a matrix cancer center reliant on interaction with other departments to execute the opening of clinical trials, the Winship Cancer Institute at Emory University (Atlanta, GA) realizes similar challenges to those reported at Vanderbilt. Several of these steps are difficult to circumvent in an academic health care center, and we believe that these processes make it more challenging for academic centers to attract pharmaceutical industry-sponsored clinical trials.
机译：致编辑：我们饶有兴趣地阅读了Dilts和Sandier的文章，并对作者在研究健康中心环境中开展肿瘤临床试验所面临的障碍进行的细致努力和坦率表示赞赏。作为依赖于与其他部门互动以开展临床试验的基础癌症中心，埃默里大学（Wind Cancer Institute）的Winship癌症研究所（乔治亚州亚特兰大）遇到了与范德比尔特（Vanderbilt）报道的挑战类似的挑战。这些步骤中的几个步骤很难在学术保健中心进行规避，我们认为，这些过程使学术中心吸引制药业赞助的临床试验更具挑战性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号